UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003533
Receipt number R000004289
Scientific Title A randomized Phase II Study of Bevacizumab in Combination with Docetaxel or S-1 in Patients with Non-Squamous Non-Small-Cell Lung Cancer Previously Treated with Platinum based Chemotherapy
Date of disclosure of the study information 2010/04/26
Last modified on 2017/05/01 09:11:11

No. Disposal Last modified on Item of update
1 Insert 2010/04/26 01:17:08
2 Update 2011/12/18 14:29:35 Last follow-up date
3 Update 2011/12/18 14:31:21 Post marketing survey by drug manufacture etc., specified by Japanese law.
Email1
4 Update 2013/10/28 08:13:12 Email
5 Update 2014/01/27 08:29:28 Recruitment status
6 Update 2015/10/27 14:24:15 Interventions/Control_2



7 Update 2016/11/28 10:42:36 Name of primary person or sponsor
Organization
8 Update 2017/05/01 09:11:11 Recruitment status
Date trial data considered complete
Date analysis concluded
URL releasing protocol
Publication of results
URL related to results and publications